Anthi Psoma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthi Psoma has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Geert van Den Bogaart
Department of Molecular Immunology, Groningen Biomolecular Sciences and Biotechnology Institute University of Groningen Groningen The Netherlands
4 shared publications Rinse de Boer
Department of Molecular Immunology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands
2 shared publications- Andreas Meinhardt
Institute of Anatomy and Cell Biology, Justus Liebig University of Giessen, Giessen, Germany
1 shared publication - Anne Hoffmann
Charité –Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Institute of Medical Genetics and Human Genetics, Berlin, Germany
1 shared publication - Björn Fischer-Zirnsak
Institute of Medical Genetics and Human Genetics, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
1 shared publication - Christian Thiel
Department I, Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Heidelberg University, Heidelberg, Germany
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Wiley in Immunology & Cell Biology
- Vol. 104 (10) , 996-1014
Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy
Interleukin‐12 (IL‐12) is a key immunoregulatory cytokine produced primarily by antigen‐presenting cells. During infection, IL‐12 orchestrates innate immune responses and shapes the nature of subsequent adaptive immunity. Specifically, by promoting interferon‐γ (IFN‐γ) production in helper and cytolytic T cells and natural killer (NK) cells, it promotes the activation of these cells and drives the differentiation of CD4 + T cells into type 1 T helper (Th1) cells. IL‐12 is a heterodimeric cytokine composed of the p35 and p40 subunits, whose coordinated expression is required for formation of the bioactive p70 molecule. The promiscuous use of these subunits within the IL‐12 cytokine family, where p40 and p35 also pair with other partners to form IL‐23, IL‐27, and IL‐35, creates structural and functional overlap that enables fine‐tuned immune regulation. Given its potent immune functions, it is not surprising that IL‐12 availability is regulated at multiple levels, including gene transcription, subunit assembly, and shared receptor signaling components. In this review, we provide an overview of IL‐12, how it is produced and secreted and its mechanisms of action. We also discuss the targeting of IL‐12 for the treatment of various diseases, including bacterial infections, autoimmune diseases, and cancer.
- 30 September 2026
- Published by Wiley in Immunology & Cell Biology
- Vol. 104 (10) , 996-1014
Open AccessInterleukin‐12: Central Roles in Immune Regulation and Disease Therapy
Interleukin‐12 (IL‐12) is a key immunoregulatory cytokine produced primarily by antigen‐presenting cells. During infection, IL‐12 orchestrates innate immune responses and shapes the nature of subsequent adaptive immunity. Specifically, by promoting interferon‐γ (IFN‐γ) production in helper and cytolytic T cells and natural killer (NK) cells, it promotes the activation of these cells and drives the differentiation of CD4 + T cells into type 1 T helper (Th1) cells. IL‐12 is a heterodimeric cytokine composed of the p35 and p40 subunits, whose coordinated expression is required for formation of the bioactive p70 molecule. The promiscuous use of these subunits within the IL‐12 cytokine family, where p40 and p35 also pair with other partners to form IL‐23, IL‐27, and IL‐35, creates structural and functional overlap that enables fine‐tuned immune regulation. Given its potent immune functions, it is not surprising that IL‐12 availability is regulated at multiple levels, including gene transcription, subunit assembly, and shared receptor signaling components. In this review, we provide an overview of IL‐12, how it is produced and secreted and its mechanisms of action. We also discuss the targeting of IL‐12 for the treatment of various diseases, including bacterial infections, autoimmune diseases, and cancer.
- Open Access
T cells compete via reverse MHC class I signaling at the synapse with dendritic cells to secure Golgi recruitment for activation
Interleukin-12 (IL-12) is a key immunostimulatory cytokine produced by dendritic cells (DCs) upon infection that plays a central role in the activation and differentiation of cytotoxic T cells. Notably, IL-12 is secreted in a highly polarized manner from late endosomes or lysosomes at the contact interface between a DC and a T cell, known as the immunological synapse. However, the signaling mechanisms initiating this spatially restricted cytokine release remain poorly defined. Here, using artificial T cell mimics, beads coated with T cell surface ligands, we show that antigen recognition induces recruitment of the DC’s microtubule organizing center (MTOC) and Golgi apparatus to the immunological synapse via reverse MHC class I signaling. Our results further indicate that the signaling pathways governing MTOC polarization are highly conserved in DCs, consistent with mechanisms described in other immune cell types. As newly synthesized IL-12 traffics through the Golgi, this intracellular reorientation facilitates localized release of IL-12 directly at the site of T cell engagement, likely enabling DCs to focus their stimulatory capacity on responsive T cells within the crowded environment of secondary lymphoid organs. Furthermore, by applying spatially patterned antibody arrays targeting MHC class I, we reveal that MTOC polarization is biased toward sites exhibiting the strongest reverse MHC class I signaling. This suggests that IL-12 is preferentially released at synapses formed with T cells displaying higher T cell receptor affinity, providing a mechanism for selection of the most potent T cell.
Open AccessT cells compete via reverse MHC class I signaling at the synapse with dendritic cells to secure Golgi recruitment for activation
Interleukin-12 (IL-12) is a key immunostimulatory cytokine produced by dendritic cells (DCs) upon infection that plays a central role in the activation and differentiation of cytotoxic T cells. Notably, IL-12 is secreted in a highly polarized manner from late endosomes or lysosomes at the contact interface between a DC and a T cell, known as the immunological synapse. However, the signaling mechanisms initiating this spatially restricted cytokine release remain poorly defined. Here, using artificial T cell mimics, beads coated with T cell surface ligands, we show that antigen recognition induces recruitment of the DC’s microtubule organizing center (MTOC) and Golgi apparatus to the immunological synapse via reverse MHC class I signaling. Our results further indicate that the signaling pathways governing MTOC polarization are highly conserved in DCs, consistent with mechanisms described in other immune cell types. As newly synthesized IL-12 traffics through the Golgi, this intracellular reorientation facilitates localized release of IL-12 directly at the site of T cell engagement, likely enabling DCs to focus their stimulatory capacity on responsive T cells within the crowded environment of secondary lymphoid organs. Furthermore, by applying spatially patterned antibody arrays targeting MHC class I, we reveal that MTOC polarization is biased toward sites exhibiting the strongest reverse MHC class I signaling. This suggests that IL-12 is preferentially released at synapses formed with T cells displaying higher T cell receptor affinity, providing a mechanism for selection of the most potent T cell.
- Open Access
- 22 November 2025
- Published by Wiley in Advanced Biology
- Vol. 10 (1) , e00226
What Is the Role of Giant Endosomal Sorting Complexes Required for Transport (ESCRT) Structures in T Cell Activation?
Our lab recently discovered uniquely large (multiple micrometres) ring‐shaped cellular structures composed of endosomal sorting complexes required for transport (ESCRT) proteins. These structures are formed by tissue infiltrating fibroblasts, dendritic cells (DCs) and macrophages but only in specific culturing conditions, notably in dense three‐dimensional collagen matrices or without serum on glass supports. We also found that the structures are devoid of F‐actin and form at membrane damage sites, suggesting a role of these structures in membrane repair. Another possibility is that these structures have a role in the immunological synapses (IS) with T cells, because they surround clusters of tetraspanins and integrins that have known roles at the IS. Therefore, we tested the hypothesis that giant ESCRT structures are present at the IS between DCs and T cells and contribute to its stability or signaling. Although we occasionally observed enrichment of ESCRT proteins at the interface between DCs, we do not observe this at the IS between human monocyte‐derived DCs (moDCs) and allogenic T cells. Thus, our data do not support a role for the giant worm‐shaped ESCRT structures at the IS, and suggest that they solely are involved in plasma membrane stability and integrity.
- 22 November 2025
- Published by Wiley in Advanced Biology
- Vol. 10 (1) , e00226
Open AccessWhat Is the Role of Giant Endosomal Sorting Complexes Required for Transport (ESCRT) Structures in T Cell Activation?
Our lab recently discovered uniquely large (multiple micrometres) ring‐shaped cellular structures composed of endosomal sorting complexes required for transport (ESCRT) proteins. These structures are formed by tissue infiltrating fibroblasts, dendritic cells (DCs) and macrophages but only in specific culturing conditions, notably in dense three‐dimensional collagen matrices or without serum on glass supports. We also found that the structures are devoid of F‐actin and form at membrane damage sites, suggesting a role of these structures in membrane repair. Another possibility is that these structures have a role in the immunological synapses (IS) with T cells, because they surround clusters of tetraspanins and integrins that have known roles at the IS. Therefore, we tested the hypothesis that giant ESCRT structures are present at the IS between DCs and T cells and contribute to its stability or signaling. Although we occasionally observed enrichment of ESCRT proteins at the interface between DCs, we do not observe this at the IS between human monocyte‐derived DCs (moDCs) and allogenic T cells. Thus, our data do not support a role for the giant worm‐shaped ESCRT structures at the IS, and suggest that they solely are involved in plasma membrane stability and integrity.
- Open Access
- 16 December 2024
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-19
Golgi pH elevation due to loss of V-ATPase subunit V0a2 function correlates with tissue-specific glycosylation changes and globozoospermia
Loss-of-function variants in ATP6V0A2, encoding the trans Golgi V-ATPase subunit V0a2, cause wrinkly skin syndrome (WSS), a connective tissue disorder with glycosylation defects and aberrant cortical neuron migration. We used knock-out (Atp6v0a2−/−) and knock-in (Atp6v0a2RQ/RQ) mice harboring the R755Q missense mutation selectively abolishing V0a2-mediated proton transport to investigate the WSS pathomechanism. Homozygous mutants from both strains displayed a reduction of growth, dermis thickness, and elastic fiber formation compatible with WSS. A hitherto unrecognized male infertility due to globozoospermia was evident in both mouse lines with impaired Golgi-derived acrosome formation and abolished mucin-type O-glycosylation in spermatids. Atp6v0a2−/− mutants showed enhanced fucosylation and glycosaminoglycan modification, but reduced levels of glycanated decorin and sialylation in skin and/or fibroblasts, which were absent or milder in Atp6v0a2RQ/RQ. Atp6v0a2RQ/RQ mutants displayed more abnormal migration of cortical neurons, correlating with seizures and a reduced O-mannosylation of α-dystroglycan. While anterograde transport within the secretory pathway was similarly delayed in both mutants the brefeldin A-induced retrograde fusion of Golgi membranes with the endoplasmic reticulum was less impaired in Atp6v0a2RQ/RQ. Measurement of the pH in the trans Golgi compartment revealed a shift from 5.80 in wildtype to 6.52 in Atp6v0a2−/− and 6.25 in Atp6v0a2RQ/RQ. Our findings suggest that altered O-glycosylation is more relevant for the WSS pathomechanism than N-glycosylation and leads to a secondary dystroglycanopathy. Most phenotypic and cellular properties correlate with the different degrees of trans Golgi pH elevation in both mutants underlining the fundamental relevance of pH regulation in the secretory pathway.
- 16 December 2024
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-19
Open AccessGolgi pH elevation due to loss of V-ATPase subunit V0a2 function correlates with tissue-specific glycosylation changes and globozoospermia
Loss-of-function variants in ATP6V0A2, encoding the trans Golgi V-ATPase subunit V0a2, cause wrinkly skin syndrome (WSS), a connective tissue disorder with glycosylation defects and aberrant cortical neuron migration. We used knock-out (Atp6v0a2−/−) and knock-in (Atp6v0a2RQ/RQ) mice harboring the R755Q missense mutation selectively abolishing V0a2-mediated proton transport to investigate the WSS pathomechanism. Homozygous mutants from both strains displayed a reduction of growth, dermis thickness, and elastic fiber formation compatible with WSS. A hitherto unrecognized male infertility due to globozoospermia was evident in both mouse lines with impaired Golgi-derived acrosome formation and abolished mucin-type O-glycosylation in spermatids. Atp6v0a2−/− mutants showed enhanced fucosylation and glycosaminoglycan modification, but reduced levels of glycanated decorin and sialylation in skin and/or fibroblasts, which were absent or milder in Atp6v0a2RQ/RQ. Atp6v0a2RQ/RQ mutants displayed more abnormal migration of cortical neurons, correlating with seizures and a reduced O-mannosylation of α-dystroglycan. While anterograde transport within the secretory pathway was similarly delayed in both mutants the brefeldin A-induced retrograde fusion of Golgi membranes with the endoplasmic reticulum was less impaired in Atp6v0a2RQ/RQ. Measurement of the pH in the trans Golgi compartment revealed a shift from 5.80 in wildtype to 6.52 in Atp6v0a2−/− and 6.25 in Atp6v0a2RQ/RQ. Our findings suggest that altered O-glycosylation is more relevant for the WSS pathomechanism than N-glycosylation and leads to a secondary dystroglycanopathy. Most phenotypic and cellular properties correlate with the different degrees of trans Golgi pH elevation in both mutants underlining the fundamental relevance of pH regulation in the secretory pathway.